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Preceding Viral Infections Do Not 
Imprint Long-Term Changes in 
Regulatory T Cell Function
Felix Rost1, Katharina Lambert1,2, Nikolas Rakebrandt1,3 & Nicole Joller1 ✉
Regulatory T cells (Tregs) maintain peripheral self-tolerance and limit immune mediated pathology. 
Like effector T cells, Tregs can specialize in TH1-dominated immune responses and co-express T-bet 
together with Foxp3. This allows for expression of CXCR3 and efficient homing to sites of TH1 responses. 
However, whether such functional specialization is paralleled by memory generation among Tregs is 
unknown. In this study, we investigated the ability of polyclonal Tregs to form functional memory in 
response to viral infection. Using adoptive transfer models to compare infection-experienced Tregs 
generated upon acute Lymphocytic Choriomeningitis Virus (LCMV) WE and Vaccinia Virus (VV) infections 
with naive Tregs, we observed no differences in their phenotype or their in vivo maintenance. When 
comparing functional properties of infection-experienced and naive Tregs, we found no differences in in 
vitro suppressive capacity nor in their ability to limit the effector response upon homologous, systemic 
or local re-challenge in vivo. Our results suggest that no functional Treg memory is generated in the 
context of systemic LCMV or VV infection, but we cannot rule out the possibility that the generation of 
Treg memory may be possible in other contexts.
Regulatory T cells (Tregs) restrain autoreactive effector T cells that have escaped negative selection in the thy-
mus to maintain self-tolerance, and negatively regulate immune responses. During infections, Treg-mediated 
immune regulation requires tight coordination to allow for efficient pathogen clearance by effector cells while 
minimizing immune-mediated damage to host cells and tissues1. In the context of a primary immune response 
pathogen-specific CD4+ effector T cells can terminally differentiate into T helper 1 (TH1), TH2, TH17 or TFH cells
2. 
Once a pathogenic threat has been neutralized, activated effector T cells undergo contraction after which only a 
small number of pathogen-specific memory T cells remain. These long-lived memory cells can, upon pathogen 
re-encounter, respond with an enhanced kinetic and magnitude and render secondary immune responses more 
effective3.
Primary viral infections predominantly induce a TH1 effector differentiation program that is driven by the 
master transcription factor T-bet, which regulates expression of the TH1-specific chemokine receptor CXCR3
4. 
In parallel to effector T cells, a fraction of the Foxp3+ Treg population can mirror this specialization program by 
co-expressing T-bet and Foxp3 and up-regulating CXCR3. This process is dynamically regulated, specific and 
essential for the effective control of TH1 polarized immune responses
5,6 and enables Tregs to accumulate in tissues 
of TH1 mediated inflammation
7. CXCR3+ Tregs were found to be potent suppressors of TH1 cells and upregulate 
markers associated with suppressive function such as LAG-3 or CD85k8. Several groups, including our own, have 
reported an induction of CXCR3+ Tregs during the acute phase of a TH1 response
5,6,8. However, whether, in line 
with memory generation in effector T cells, this functional specialization also leads to long-term changes in Tregs 
and the generation of Treg memory, is still unclear.
Several important aspects separate effector from memory T cells. These include long-term persistence in the 
absence of cognate antigen and enhanced response kinetics and/or function upon homologous re-challenge1. 
However, applying these criteria to establish if Treg memory can be generated is problematic. Firstly, classical 
memory markers of effector T cells such as CD44 are already expressed by a considerable fraction of Tregs under 
homeostatic conditions9, and indeed until today no reliable markers of memory Tregs have been identified
1. 
However, because T-bet and CXCR3 were reported to be induced and stably expressed by Tregs during and after 
acute TH1 responses
5,6 both may represent useful markers to identify cells with the capacity to generate memory. 
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Secondly, detecting persistence of non-self-specific memory Tregs in the absence of their cognate antigen in vivo 
is complicated by the fact that the Treg TCR repertoire is presumed to be largely skewed towards recognizing 
self-antigen10 and thus pathogen-specific Tregs may be low in number for some pathogens, or completely absent for 
others. This observation does, however, not preclude the existence of pathogen-specific Tregs in vivo and, indeed, 
several research groups have successfully identified pathogen-specific Tregs by tetramer staining in mice
11–14. 
Consequently, murine in vivo models of acute, transient infection may allow to examine pathogen-specific mem-
ory formation by characterizing the responses and in vivo maintenance of an inflammation-experienced, poly-
clonal Treg population in general and of T-bet+ or CXCR3+ Tregs in particular under physiologic conditions and in 
the absence of cognate antigen. In accordance with this, several research groups have used TCR-transgenic Tregs to 
address memory formation in models of viral infection in vivo. Adoptively transferred Tregs specific for influenza 
A virus (IAV) hemagglutinin (HA) expanded following an acute infection with a recombinant virus that encoded 
HA, then underwent contraction and upon homologous re-challenge expanded more rapidly and significantly 
reduced the recall expansion of effector T cells15. Similar observations including Treg expansion, contraction and 
accelerated re-expansion during homologous viral re-challenge were made by another group that addressed the 
responses of TCR-transgenic Tregs specific for the IAV nucleoprotein
16. However, whether these findings can also 
be applied to the endogenous, polyclonal Treg population is still unclear.
In this study, we compared the phenotypic and functional properties of polyclonal Tregs from naive 
and infection-experienced mice using two models of homologous viral re-challenge. We show that 
infection-experienced, polyclonal Tregs do not exhibit superior maintenance in the absence of an immunologic 
challenge and do not show marked differences in their phenotype. Furthermore, naive and infection-experienced 
Tregs did not differ in their suppressive capability and do not alter systemic or localized anti-viral effector T cell 
responses upon homologous systemic or tissue localized re-challenge in vivo. In summary, we did not observe Treg 
memory responses within the endogenous polyclonal Treg pool.
Results
In vitro suppressive capacity of Tregs from infection-experienced and naive mice is comparable. 
Expression of the transcription factor T-bet and the downstream chemokine receptor CXCR3 by Tregs in viral 
infections was shown to be dynamically regulated8 and essential for the control of TH1 polarized immune 
responses5,6. However, despite clear evidence that the expression of transcription factors such as T-bet5, Rbpj17, 
IRF418, or STAT319 by Tregs is required to regulate TH1, TH2 or TH17 immune responses, it is still unclear if such 
phenotypic polarization is also paralleled by memory formation. It was shown that an acute LCMV infection 
induces the expression of T-bet and CXCR3 as well as Treg effector molecules such as LAG-3, TIM-3, and CD85k 
at the peak of the infection8. However, 30–60 days after primary infection with LCMV or VV the absolute Treg 
numbers in infection-experienced or naive mice were comparable across lymphoid and non-lymphoid organs 
(Supplementary Fig. 1A,B). Similarly, we observed no differences in the MFI of T-bet and the frequency of 
CXCR3+ Tregs (Supplementary Fig. 1C,D), nor in the frequency of neuropilin-1- peripherally induced pTregs 
(Supplementary Fig. 1E,F). Still, we surmised that the infection-experienced Treg pool may be enriched for 
memory Tregs of enhanced suppressive capacity that may not be marked by enhanced expression of CXCR3 and 
thus not be readily detectable within the total Treg population. Additionally, even though CXCR3+ Tregs were 
isolated at similar frequencies from naive or infection-experienced mice (Supplementary Fig. 2A) their sup-
pressive capacity may still be different because only Tregs from infection-experienced mice had been exposed to 
a potent inflammatory environment. Thus, we wanted to determine whether there might be differences in the 
suppressive capacity of polyclonal infection-experienced or naive Tregs. To address this question, we compared 
their ability to suppress TH1 effector cells in an in vitro suppression assay. To generate infection-experienced Tregs, 
Foxp3-GFP reporter mice were acutely infected with LCMV to induce a potent TH1 polarized immune response. 
CD4+ Foxp3-GFP+ Tregs were sorted from LCMV-experienced (day 30) or naive Foxp3-GFP reporter mice and 
co-cultured with anti-CD3 stimulated CD4+GFP− effector T cells from acutely LCMV infected mice in an in 
vitro suppression assay. We observed a pronounced and similar suppression of proliferation of CD4+GFP− effec-
tor T cells from LCMV infected mice by both naive or LCMV-experienced Tregs (Fig. 1A,B). The quantification of 
the cytokine IFN-γ in the supernatants of the suppression assays confirmed the equivalent suppressive capacity of 
both Treg populations (Fig. 1C). We also observed similar suppression of proliferation of CD4+GFP− effector T 
cells isolated from naive donor mice by Tregs from naive or LCMV-experienced mice (Supplementary Fig. 2B,C). 
Next, we wanted to address whether LCMV-experienced Tregs might show superior LCMV-specific suppression. 
To this end, we tested the ability of naive and LCMV-experienced Tregs to suppress antigen-specific stimulation 
of LCMV gp61-specific SMARTA effector T cells in an in vitro suppression assay. We found that neither naive 
nor LCMV-experienced Tregs were able to suppress SMARTA cell proliferation despite the fact that both Treg 
populations were functional when stimulated with anti-CD3 (Supplementary Fig. 2D). To determine whether 
LCMV gp66-specific Tregs are at all present in these Treg populations, we next performed a gp66 tetramer staining. 
We found that splenic CD4+ Foxp3+ Tregs and Foxp3− effector T cells of naive mice indeed harbored LCMV 
gp66-specific cells at similar frequencies (Fig. 1D). However, while gp66-specific CD4+ effector T cells were 
detectable at higher numbers 30 days after acute LCMV infection, the absolute numbers of gp66-specific Tregs 
remained unchanged in LCMV-experienced mice, suggesting that these cells, while detectable, did not expand 
in vivo (Fig. 1E).
Tregs from infection-experienced and naive mice are maintained equally well in vivo. Assessing 
the suppressive capacity of Tregs in an in vitro suppression assay is a useful, yet biologically constrained 
means to compare Treg function. We hypothesized, that potential differences between Tregs from naive and 
infection-experienced mice might emerge in vivo because in vitro suppression assays do not allow to capture 
all possible suppressive mechanisms that can be employed by Tregs such as e.g. the impairment of effector T cell 
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recruitment to inflammatory sites20. To obtain a more comprehensive overview of the functionality and relevance 
of potential memory formation, we next studied Tregs in in vivo models of infection.
One defining feature of T cell memory is the stable maintenance of antigen-specific memory T cells 
long after the cognate antigen has been cleared1. We thus wondered if a polyclonal Treg pool isolated from 
infection-experienced mice, and thus potentially enriched for memory Tregs, would show signs of prolonged in 
vivo maintenance in the absence of an immune challenge. To test this, we performed adoptive co-transfers of con-
genically marked polyclonal CD4+GFP+ Tregs isolated from naive (CD45.1+) or LCMV-experienced (CD45.2+) 
Foxp3-GFP reporter mice at a 1:1 ratio into naive CD90.1+ recipient mice and the purity of the transferred cell 
population was confirmed by Foxp3 staining (Fig. 2A). The recipient mice were then sacrificed 21 to 28 days after 
transfer to compare the phenotype and absolute numbers of the CD45.1+ or CD45.2+ recovered Tregs. Tregs recov-
ered from the spleen of recipient mice showed similar frequencies of cells expressing the IL-2 receptor alpha chain 
(CD25), the chemokine receptor CXCR3, the activation marker CD44, the co-inhibitory receptor TIGIT, and the 
transcription factor Ki67, which marks cells that actively undergo cell cycling (Fig. 2B). Thus, there appeared to be 
no selective, preferential in vivo maintenance or enrichment of CXCR3+ LCMV-experienced compared to naive 
Tregs. We also found that the 1:1 ratio of transferred naive and LCMV- experienced Tregs was maintained in spleen, 
pooled peripheral lymph nodes, bone marrow and lung of the recipient mice and we recovered similar absolute 
numbers of both populations in all organs tested (Fig. 2C). This suggested that the in vivo maintenance of naive 
or LCMV-experienced Tregs is similar across primary and secondary lymphoid organs as well as peripheral tissues 
such as the lung and there seemed to be no preferential homing of LCMV-experienced Tregs to any particular site. 
Overall, we did not observe any differences in the phenotype and in vivo maintenance of polyclonal Tregs isolated 
from naive or LCMV-experienced donor mice.
Treg cell phenotype and function in systemic viral re-challenges are comparable. Next, we com-
pared the in vivo responses of naive or infection-experienced Tregs in homologous viral re-challenges and quanti-
fied their effect on the endogenous anti-viral effector T cell response. We found that adoptive transfer of 5 × 105 
polyclonal Tregs is sufficient to dampen the endogenous effector T cell response (Supplementary Fig. 3) and thus 
used this as a basis to assess the suppressive function of naive vs. infection-experienced Tregs in vivo. To this end, 
Figure 1. Infection-experienced Tregs show trend for higher in vitro suppressive capacity. CD4+GFP+ Tregs 
were sorted from naive or LCMV-experienced Foxp3-GFP reporter mice and co-cultured with CD4+GFP- 
effector cells isolated from acutely LCMV infected donor mice in the presence of soluble anti-CD3 (1 µg/ml) 
and irradiated splenic APCs isolated from naive mice for 2 days, then [3H]thymidine was added for 18–22 h 
and [3H]thymidine incorporation was quantified to determine proliferation. Target cell proliferation (A) 
and calculated Treg-mediated suppression (B) are shown. (C) The concentration of IFN-γ in the suppression 
assay supernatants harvested after 48 h of co-culture was determined by cytometric bead assay. (Mean ± SD; 
biological replicates: no Tregs, naive Tregs, memory Tregs n = 6; 2 independent experiments) (one way ANOVA 
and multiple comparisons test, *p < 0.05, **p < 0.01, ***p < 0.001). (D) Splenic T cells from naive or 
LCMV-experienced mice (>30 days post infection) were stained using gp66 tetramers to detect LCMV-
specific CD4+Foxp3+ Tregs or CD4+Foxp3- effector T cells. Frequencies and absolute numbers are shown. 
(Mean ± SD; biological replicates: naive n = 8, LCMV-experienced n = 9; 3 independent experiments) (t Test, 
****p < 0.0001).
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we isolated bulk Tregs from naive or LCMV-experienced Foxp3-GFP reporter mice >30 days after the primary 
infection and adoptively transferred 5 × 105 Tregs into separate groups of naive, congenically marked recipient 
mice. 1 day after the adoptive transfer, recipient mice were challenged with LCMV and 10 days later the spleens 
were harvested and the phenotype of the transferred Tregs and the endogenous effector T cell responses were com-
pared. We already showed earlier that the phenotype of naive or LCMV-experienced Tregs was comparable at the 
day of transfer (Supplementary Fig. 2A). The absolute numbers of naive or LCMV-experienced Tregs recovered 
from the spleen of recipient mice on day 10 after systemic viral re-challenge did not differ (Fig. 3A). This indicated 
that Tregs isolated from LCMV-experienced mice did not show signs of more pronounced expansion or superior 
maintenance upon homologous LCMV re-challenge in vivo. Furthermore, we did not observe differences in the 
frequency of T-bet+ or CXCR3+ cells among naive or LCMV-experienced Tregs, indicating that the homologous 
re-challenge did not induce a preferential enrichment of TH1 suppressing Tregs among the LCMV-experienced Treg 
population (Fig. 3B). Also, the expression of the memory and activation marker CD44, as well as the co-inhibitory 
receptor TIGIT did not differ. The frequency of Ki67+ cells was also similar and suggested no differences in cell 
cycling between Tregs isolated from naive or LCMV-experienced mice.
To determine whether Tregs from infection-experienced or naive mice differed in their ability to suppress 
effector T cells in vivo, we compared the endogenous effector T cell response after LCMV-specific ex vivo pep-
tide re-stimulation. Again, we did not observe any differences in the frequencies or absolute numbers of splenic 
IFN-γ+ CD8+ or CD4+ effector T cells in recipients of naive or LCMV-experienced Tregs (Fig. 3C). Similarly, 
no differences were detected in the frequencies or absolute numbers of TNF-α+ CD8+ or CD4+ effector T cells 
(Supplementary Fig. 4A). Also, re-stimulation of total splenocytes using PMA/Ionomycin revealed no differences 
in the frequency or absolute number of IFN-γ+ CD8+ or CD4+ effector T cells (Supplementary Fig. 4B).
To exclude the possibility that the potent anti-viral immune response elicited by LCMV21 could mask poten-
tially small differences in the Treg phenotype or their impact on an ongoing anti-viral immune response, we per-
formed an analogous second set of experiments using Vaccinia Virus (VV) instead of LCMV. As for LCMV, 
the phenotype of Tregs isolated from naive or VV-experienced mice was similar (Supplementary Fig. 1B,D,F and 
Supplementary Fig. 2A) and we adoptively transferred these bulk populations into separate groups of congenically 
Figure 2. Infection-experienced and naïve Tregs are equally well maintained in vivo. CD4+GFP+ Tregs were 
sorted from naive (CD45.1) or LCMV-experienced (CD45.2) Foxp3-GFP reporter mice and 500’000 of 
each population were adoptively co-transferred i.v. into naive CD90.1+ recipient mice. Organs from Treg 
recipients were harvested and analyzed by flow cytometry 21–28 days after transfer. (A) Characterization 
of Tregs from naive and LCMV-experienced mice before transfer. Input ratio (top) and purity (bottom) are 
shown in representative plots. (B) On day 21–28 post transfer, expression of CD25, CXCR3, CD44, TIGIT 
and Ki67 was determined in naive or LCMV-experienced CD4+Foxp3+ Tregs isolated from the spleens of 
recipient mice. Representative plots (top) and summary plots (bottom) are depicted. (C) Chimerism (left) and 
absolute numbers (right) of CD90.2+ Tregs recovered from the indicated organs on day 21 to 28 post transfer. 
(B,C) Cumulative data (Mean ± SD; biological replicates: Spleen n = 7, pLNs n = 4, BM n = 4, Lung n = 3; 4 
independent experiments) (t Test, *p < 0.05, **p < 0.01, ***p < 0.001).
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Figure 3. Naive and infection-experienced Tregs have comparable phenotypes in systemic, homologous 
challenges. CD4+GFP+ Tregs were sorted from naive, LCMV- (A–C) or VV- (D–F) experienced 
CD45.1 + Foxp3-GFP reporter mice >30 days after the primary infection and 500’000 of each population 
were adoptively transferred into separate groups of CD45.2+ recipient mice followed by acute LCMV (A–C) 
or VV (D–F) infection. (A–C) Treg recipients were sacrificed 10 days post LCMV infection and the transferred 
Tregs characterized in the spleen. (A) Frequencies of transferred naive or LCMV-experienced Tregs within the 
total Treg population (top) and absolute numbers of recovered, transferred Tregs (bottom). (B) Naive or LCMV-
experienced transferred Tregs were phenotypically characterized by flow cytometry. Representative plots (top) 
and cumulative data (bottom) depicting frequencies of marker positive cells among the transferred Tregs. (C) 
Splenocytes of recipient mice were re-stimulated with LCMV peptides (gp33 and gp61) for 4 h followed by 
intracellular cytokine staining for IFN-γ. (Mean ± SD; biological replicates: naive n = 4–14, LCMV-experienced 
n = 3–10; 3 independent experiments). (D–F) Treg recipients were sacrificed 7 days post VV infection and 
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marked recipient mice and infected them with VV one day after the transfer. 7 days after the systemic viral 
re-challenge the spleens of the recipient mice were harvested for analysis. As for LCMV, we did not observe differ-
ences in the absolute numbers of naive or VV- experienced Tregs recovered from the spleen (Fig. 3D). Flow cyto-
metric analysis did also not show any differences in the frequency of T-bet+ or CXCR3+, CD44+, TIGIT + or 
Ki67+ cells among the transferred Tregs (Fig. 3E). Furthermore, no differences in the frequency of IFN-γ+ or 
TNF-α+ CD8+ effector T cells were observed after VV-specific re-stimulation (Fig. 3F, Supplementary Fig. 4C) 
or of IFN-γ+ CD8+ or CD4+ effector T cells after re-stimulation of total splenocytes using PMA/Ionomycin 
(Supplementary Fig. 4D).
Overall, neither LCMV- nor VV-experienced Tregs showed enhanced expression of T-bet or CXCR3, increased 
activation, or cell cycling. In line with this, the absolute numbers of naive or infection-experienced Tregs that we 
recovered from the spleen of recipient mice did not differ. We also did not observe differences in the magnitude 
of the endogenous anti-viral CD8+ or CD4+ effector T cell response in the presence of infection-experienced 
compared to naive Tregs. This suggested that in our model system of adoptive Treg transfer the presence of 
infection-experienced Tregs did not alter the course of the anti-viral immune response nor did the Tregs differ in 
their phenotype for the markers that we investigated.
Treg cell responses in localized viral re-challenges are comparable. We found that in systemic 
homologous re-challenges the phenotype and the capacity of naive or infection-experienced Tregs to regulate 
effector T cell responses was comparable. Nevertheless, as virus-specific memory Tregs were shown to be able to 
expand in vivo15,16,22, and because expression of T-bet has been reported to be stable over time5,6 we hypothesized 
that infection-experienced Tregs might, upon viral re-challenge, show faster recruitment to the site of a localized 
viral infection compared to naive Tregs. This is because T-bet-dependent expression of CXCR3 has been sug-
gested to allow Tregs to co-localize with CXCR3+ TH1 effector T cells at inflammatory sites
6,7. We thus analyzed 
whether infection-experienced Tregs might show enhanced suppressive capacity in a localized re-challenge model 
of infection. Injection of LCMV into the footpad of mice induces a tissue localized anti-viral immune response 
that results in effector T cell influx and tissue swelling23. Similarly, epicutaneous VV infection in the ear results in 
a localized infection with CXCR3-dependent and infection site-restricted recruitment of virus-specific CD8+ T 
cells24. We thus employed these two localized models of infection and tested if infection-experienced Tregs could 
migrate more efficiently to sites of ongoing TH1 mediated inflammation and if they could reduce the local effector 
response (as measured by tissue swelling) at the infected site. We also assessed the endogenous effector T cell 
responses to address the possibility of a potentiated immune regulation exerted by infection-experienced Tregs.
In the LCMV model, we performed subcutaneous infections in the hind footpad of mice that had received 
either LCMV-experienced or naive Tregs (Fig. 4A). The swelling of the infected site was measured daily and mice 
were sacrificed 13 days after local LCMV re-challenge. We did not observe differences in the swelling of the 
footpads between recipients of naive or LCMV-experienced Tregs (Fig. 4B), nor did we observe differences in 
the frequencies of IFN-γ+ CD8+ or CD4+ effector T cells in the footpad draining popliteal lymph node after 
virus-specific or unspecific re-stimulation (Fig. 4C and Supplementary Fig. 5A). In line with these results, recip-
ients of naive or VV-experienced Tregs did not show differences in response to epicutaneous VV re-challenge, 
neither in ear swelling (Fig. 4D,E), nor in the frequency of IFN-γ producing CD8+ effector T cells in the ear 
draining cervical lymph node (Fig. 4F), nor upon stimulation with PMA/Ionomycin (Supplementary Fig. 5B). 
Furthermore, neither naive nor infection experienced Tregs could be detected in the footpad draining or ear drain-
ing lymph node after local LCMV or VV infection, respectively. In summary, we could not observe differences in 
the recruitment or suppressive function of infection experienced and naive Tregs.
Discussion
In this study, we investigated the phenotypic and functional features of polyclonal, infection-experienced Tregs in 
vitro, and in different TH1 responses in vivo. Using adoptive (co-)transfer experiments we found that neither the 
maintenance nor the suppressive function of infection-experienced Tregs was altered in vivo. Homologous, sys-
temic viral re-challenges using LCMV or VV revealed that infection-experienced Tregs did not display an altered 
composition, activation, nor differences in cell cycling. Furthermore, infection-experienced polyclonal Tregs were 
unable to significantly dampen systemic or localized effector T cell responses compared to Tregs isolated from 
naive mice. Overall these results suggest that Tregs, which have experienced a viral infection do not show an altered 
phenotype nor function compared to naive Tregs and thus do not display characteristics of a memory response.
Addressing the possibility that Tregs generate immunological memory is uniquely challenging and conflicting 
evidence for and against it has been reported. Several studies employed TCR transgenic Tregs and presented com-
pelling evidence that pathogen-specific Tregs can generate memory cells. In an Influenza A virus (IAV) infection 
model, virus-specific Tregs underwent pronounced proliferation and contraction phases and yielded a small popu-
lation of virus-specific Tregs that persisted long-term and, upon antigen-specific re-challenge, were recruited more 
effectively to the lung, expanded more rapidly and potently suppressed effector T cell expansion and cytokine pro-
duction16. Very similar experiments were performed by another group that also reported enhanced production 
the transferred Tregs characterized in the spleen (D). Frequencies of transferred naive or VV-experienced Tregs 
within the total Treg population (top) and absolute numbers of recovered, transferred Tregs (bottom). (E) Naive 
or VV-experienced transferred Tregs were phenotypically characterized by flow cytometry. Representative plots 
(top) and cumulative data (bottom) depicting frequencies of marker positive cells among the transferred Tregs. 
(F) Splenocytes of recipient mice were re-stimulated with VV peptide for 4 h followed by intracellular cytokine 
staining for IFN-γ. (Mean ± SD; biological replicates: naive n = 6, VV-experienced n = 8; 2 independent 
experiments) (t Test, *p < 0.05, **p < 0.01, ***p < 0.001).
7SCIENTIFIC REPORTS |         (2020) 10:8350  | https://doi.org/10.1038/s41598-020-65212-9
www.nature.com/scientificreportswww.nature.com/scientificreports/
of IL-10 by influenza virus-specific Tregs upon antigen-specific re-challenge
15. In our study, we went beyond the 
limitations set by models that use TCR transgenic cells and performed adoptive transfers of polyclonal Tregs from 
naive or infection-experienced donor mice. Interestingly, we found no evidence of Treg memory generation or 
more potent regulation of effector T cell responses.
Aside from the potentially enhanced functionality of memory Tregs, other researchers have addressed their abil-
ity to migrate to peripheral sites and have shown that Tregs can form tissue resident memory cells
22. A set of studies 
investigated responses of TCR transgenic Tregs in a model of inducible antigen expression in keratinocytes
25 and 
Figure 4. Adoptive transfer of infection experienced Tregs does not alter tissue swelling and effector T cell 
responses in localized, homologous viral challenges. CD4+GFP+ Tregs were sorted from naive, LCMV-
experienced (A–D) or VV-experienced (E–I) CD45.2+ Foxp3-GFP reporter mice 30 days after the primary 
infection and 500’000 of each population were adoptively transferred into separate groups of CD45.1+ recipient 
mice. Recipients of naive, LCMV- or VV-experienced Tregs were infected subcutaneously into the hind footpad 
with LCMV (A–D), or epicutaneously into the ears with VV (E–I) and the swelling of the infected site was 
monitored daily for 13 or 8 days, respectively, with a spring loaded caliper. On the final day of the experiment 
mice were sacrificed and T cell responses in the site draining popliteal lymph node (A–D), or cervical lymph 
node (E–I) characterized by FACS. (A) Schematic outline of the homologous LCMV challenge experiment. 
(B) Thickness of the footpads of recipients of naive or LCMV-experienced Tregs infected with LCMV in the 
right hind footpad or mock infected with PBS on the contralateral side. (C) Cells from the footpad draining 
popliteal lymph node of recipient mice of the PBS treated side were pooled and from the infected side treated 
individually and re-stimulated with LCMV peptides (LCMV gp61 and gp33, 4 h) followed by intracellular 
cytokine staining for IFN-γ. Representative plots (left) and summary graphs (right) are shown. (Mean ± SD; 
biological replicates: naive n = 6, LCMV-experienced n = 5; 2 independent experiments) (D) Schematic outline 
of the experimental setup to elicit homologous, localized immune challenges using VV in the ear. (E) Thickness 
of the ears of recipients of naive or VV-experienced Tregs that were either infected with VV epicutaneously 
or mock injected with PBS. (F) Cells from the ear draining cervical lymph node of recipient mice of the PBS 
treated side were pooled and from the infected side treated individually and re-stimulated with VV peptide (4 h) 
followed by intracellular cytokine staining for IFN-γ. Representative plots (left) and summary graphs (right) are 
shown. (Mean ± SD; biological replicates: naive n = 6, VV-experienced n = 6; 2 independent experiments) (t 
Test*p < 0.05, **p < 0.01, ***p < 0.001).
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found robust activation, proliferation and migration of antigen specific Tregs to the inflamed skin, reported persis-
tence of a tissue resident, antigen-specific Treg population in the absence of antigen expression and an accelerated 
response kinetic and disease amelioration upon local antigen re-expression22. The fact that in our systemic and 
local viral re-challenges we could not observe enhanced responses by infectionexperienced Tregs may be due to the 
fact that systemic viral infections, unlike tissue localized infections, may not be suited to generate Treg memory. It is 
possible that memory Tregs are primarily generated in peripheral tissues and persist as tissue resident memory cells, 
in which case we would not be able to detect them in our experimental models. Nevertheless, based on the reported 
sustained expression of T-bet5,6 and pronounced re-expansion of TCR transgenic memory Tregs in vivo
15,16,22 one 
could suspect an enhanced capacity for homing of memory Tregs to sites of local TH1 mediated inflammation. 
However, we did not find evidence for enhanced Treg homing in local re-challenges. In addition, we were unable to 
recover any infection-experienced Tregs from the lymph nodes that drained the site of infection. While our experi-
mental system allows for the analysis of a polyclonal Treg response, we could not observe any expansion of Tregs spe-
cific for the immunodominant LCMV effector T helper epitope gp66 in vivo. This is in contrast to previous reports, 
where HA-specific Tregs were found to expand during antigen-specific primary and secondary challenge in vivo
15. 
However, these observations were made in a TCR transgenic model system, where TCR transgenic Tregs receive 
very strong TCR stimulation. It is possible that the LCMV-specific Tregs we detected in naive mice receive weaker 
TCR signals in vivo, possibly because they represent self-specific Tregs with weak cross-reactivity for LCMV
26. 
Treg-mediated immune regulation has been implicated in playing a role in various viral infections such as Friend 
Virus27, Cytomegalovirus28, hepatitis C virus29, or influenza virus infections30. Interestingly, influenza virus-specific 
Tregs have been found to potently regulate anti-viral effector T cells responses in influenza infection in vivo and 
show enhanced suppression upon re-challenge16. However, it remains to be elucidated whether virus-specific Tregs 
are also generated against other viruses. Our results suggest that LCMV-specific Tregs do not undergo expansion 
upon LCMV infection in vivo, possibly due to low affinity for LCMV antigens, which may have precluded memory 
generation. Indeed, despite clear evidence for the immunoregulatory functions of Tregs, Treg memory generation is 
absent in infections with, for instance, Friend Virus27, MCMV28, or HSV31 for which pathogen-specific Tregs have 
not been described so far. Thus, despite earlier reports of murine Tregs specific for various pathogens including 
LCMV11–14 it still remains to be established if such cells do get activated in a viral infection and can generate func-
tional memory. Similarly, several studies also presented evidence that argued against Treg memory. One recent study 
reported that activation-induced changes in gene expression by polyclonal Tregs in a self-resolving TH1 polarized 
autoimmune disease were either fully or significantly reversed within 60 days of onset and resolution of the dis-
ease32. This suggested that no functional Treg memory was formed in a systemic TH1 polarized immune response 
and our data would suggest a similar conclusion. However, another study by the same group employed an intricate 
T-bet dual reporter system and showed that polyclonal Tregs that had expressed T-bet at the peak of a primary 
immune response directed against Listeria monocytogenes expanded more robustly than Tregs that de novo upreg-
ulated T-bet in a secondary, homologous re-challenge with the same pathogen6. This observation suggested that 
infection-experienced T-bet+ Tregs are maintained long-term and retain a capacity for enhanced proliferation upon 
homologous re-challenge. Our data does, however, not confirm these findings as we did not observe increased 
absolute numbers, nor frequencies of T-bet+ , CXCR3+ or Ki67+ cells among infection-experienced Tregs during 
homeostasis in donor animals nor during homologous systemic or localized re-challenge. As such, our study would 
argue against LCMV or VV pathogen-specific Treg memory but it will be important to confirm this finding in other 
models that allow for the analysis of polyclonal, non-TCR transgenic Treg populations.
Methods
Mice, pathogens, and infections. C57BL/6 (B6) mice were purchased from Janvier Laboratories and 
Foxp3-GFP.KI reporter33 and SMARTA34 mice have been described previously. All mice were housed and bred in 
SPF or OHB facilities at LASC Zurich, Switzerland. All experiments were reviewed and approved by the cantonal 
veterinary office of Zurich and were performed in accordance with Swiss legislation.
Lymphocytic choriomeningitis virus (LCMV) WE was propagated on L929 fibroblast cells, Vaccinia Virus 
(VV) on BSC40 cells. Sex- and age-matched mice, 6–12 weeks of age were infected i.v. with 200 ffu LCMV, or 
i.p. with 2 × 106 ffu VV. For footpad infections 50 µL of PBS containing 500 ffu of LCMV were injected s.c. into 
the right hind footpad23. Epicutaneous ear infections were modified from a previous report24 and performed by 
piercing the ear five times with a bifurcated needle that was dipped into VV stock (7.65 × 108 ffu/mL) in between 
punches. The contralateral footpads or ears served as a control and were mock infected in an identical manner 
using sterile PBS. Swelling of the infected site was monitored daily with a spring-loaded caliper.
Isolation of leukocytes. Harvested spleens or lymph nodes were dissociated by carefully pushing them 
through a fine metal mesh or 70 µm cell strainer, respectively, followed by red blood cell lysis using ACK buffer 
(155 mM NH4Cl, 1 mM KHCO3, 0.1 mM NA2EDTA in ddH2O, pH 7.2–7.4) for spleen samples, prior to staining 
for flow cytometry. Bone marrow was flushed out from the femur and tibia-fibula. For isolation of lung cells, mice 
were perfused with sterile PBS, lungs resected and digested in RPMI medium containing DNase I (200 µg/ml, 
VWR) and Collagenase I (2.4 mg/ml, Gibco), and dissociated using a gentleMACS (Miltenyi) according to the 
manufacturer’s protocol. Leukocytes were purified over a 30% Percoll (GE Healthcare) gradient and then stained 
for flow cytometry.
Flow cytometry. Single cell suspensions from the indicated organs were surface stained with 
fluorophore-conjugated antibodies for 20 min, followed by fixation/permeabilization for 45 min using the Foxp3 
Staining Buffer Set (eBioscience) for transcription factor staining or 10 min using BD Fixation/Permeabilization 
Solution kit (BD Bioscience) for intracellular cytokine staining, followed by intracellular staining for 40 min at 
room temperature. For gp66 tetramer staining, cells were pre-incubated with APC-conjugated tetramer for 20 min 
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before surface staining for additional markers. For intracellular cytokine staining, isolated bulk splenocytes were 
re-stimulated using phorbol 12-myristate 13-acetate (PMA, 50 ng/mL) and Ionomycin (1 µg/ml), αCD3 (2 µg/ml, 
BioXcell), the immunodominant LCMV peptides gp61 and gp33 (1 mg/ml; gp61: GLKGPDIYKGVYQFKSVEFD; 
gp33-41: KAVYNFATM) or the immuno-dominant VV CD8+ T cell epitope (10 mM, TSYKFESV, GenScript) 
for 4 h at 37 °C in the presence of Brefeldin A (5 µg/mL, BioLegend). Fluorophore-conjugated antibodies against 
murine CD4 (RM4–5 or GK1.5), CD8 (53–6.7), Foxp3 (FJK-16s), T-bet (4B10), CXCR3 (CXCR3-173), CD44 
(IM7), CD85k (H1.1), TIGIT (1G9), CD25 (PC61), IFN-γ (XMG1.2), TNF-α (MP6-XT22) or Ki-67 (16A8) were 
purchased from BioLegend, eBioscience, or R&D Systems. The LIVE/DEAD Fixable Near-IR Dead Cell Stain 
Kit (Invitrogen) was used to exclude dead cells. Counting beads (CountBright, Invitrogen) were added before 
flow cytometric acquisition to determine absolute cell numbers. Data were acquired on a BD LSRFortessa or BD 
FACSCanto II cytometer (BD Biosciences). Data were analyzed using Flowjo Software (Flowjo, LLC) and where 
necessary target populations were concatenated to simplify analysis.
Cell sorting by FACS. Total CD4+ T cells from virus-infected or naive control Foxp3-GFP.KI mice 
were isolated from bulk splenocytes and peripheral lymph nodes (inguinal, brachial, axillary, cervical) using 
anti-CD4 positive or negative selection beads (BioLegend), followed by FACS sorting. Tregs were FACS sorted 
as CD4 + GFP + cells from Foxp3-GFP reporter mice. Cell sorting was performed on a FACSAria III (BD 
Biosciences).
Adoptive cell transfers. 5 × 105 sorted CD4 + GFP + Tregs from infection-experienced (day > 30) or naive 
Foxp3-GFP reporter mice suspended in 200 µl PBS were adoptively transferred by i.v. injection into congenically 
marked naive recipient mice. The in vivo maintenance of the transferred Treg cells was assessed 21–28 days post 
transfer in the indicated organs. For systemic and localized homologous challenges the Treg recipient mice were 
infected with LCMV or VV one day after the adoptive transfer.
Treg in vitro suppression assays. Suppression assays were performed as described before
8. Briefly, cells 
were cultured in DMEM medium supplemented with 10% heat-inactivated FCS, β-mercaptoethanol (50 mM), 
sodium pyruvate (1 mM, Gibco), non-essential amino acids (Gibco), MEM vitamins (Gibco), penicillin (50 U/
mL, Gibco), streptomycin (50 µg/mL, Gibco), and Glutamine (2 mM, Gibco). TH1 effector cells were isolated by 
FACS from spleen and lymph nodes of day 10–14 LCMV-WE infected Foxp3-GFP reporter mice as CD4+GFP− 
cells. CD4+GFP− effector cells (4 × 104 cells/well) and CD4+GFP+ Treg cells were co-cultured in triplicate 
in the presence of soluble anti-CD3 (1 µg/ml, BioXcell) and irradiated splenic APCs (2 × 105/well) to provide 
co-stimulation at 37 °C and 5% CO2. After 48 h cells were pulsed with 1 µCi [3H]thymidine (PerkinElmer) for 
an additional 18–22 h, then harvested and [3H]thymidine incorporation was assessed to analyze T cell prolif-
eration. Percent suppression = ([mean value of C.P.M. of wells with CD4+Foxp3− cells alone - C.P.M. of well 
with the indicated ratio of effector T: Treg cells]/[mean C.P.M. of wells with CD4+Foxp3− effectors alone])*100. 
Cytokine secretion was determined in supernatants harvested after 48 h of co-culture using the LEGENDplex 
Assay according to the manufacturer’s instructions (BioLegend).
Statistical analysis. Statistical significance between two individual groups was determined using two-sided 
t Test, for more than two groups one-way ANOVA was used. Assessment was performed using Prism7 or R soft-
ware. Statistical significance values are indicated as follows: p < 0.05 (*), p < 0.01 (**) and p < 0.001 (***).
Ethical approval and informed consent. All animal experiments were reviewed and approved by the 
cantonal veterinary office of Zurich and were performed in accordance with Swiss legislation as detailed in the 
methods section.
Data availability
All relevant data of the article and its supplementary files are available from the corresponding author upon 
request.
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